Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.
Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, Jones B, Chapman R, Cocking L, Wilks J, Webb D, Carroll C; PD STAT Study Group. Stevens KN, et al. Among authors: chapman r. JAMA Neurol. 2022 Dec 1;79(12):1232-1241. doi: 10.1001/jamaneurol.2022.3718. JAMA Neurol. 2022. PMID: 36315128 Free PMC article. Clinical Trial.
Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial.
Carlton EW, Ingram J, Taylor H, Glynn J, Kandiyali R, Campbell S, Beasant L, Aziz S, Beresford P, Kendall J, Reuben A, Smith JE, Chapman R, Creanor S, Benger JR. Carlton EW, et al. Among authors: chapman r. Heart. 2020 Oct;106(20):1586-1594. doi: 10.1136/heartjnl-2020-316692. Epub 2020 May 5. Heart. 2020. PMID: 32371401 Free PMC article. Clinical Trial.
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
Gonzalez-Robles C, Weil RS, van Wamelen D, Bartlett M, Burnell M, Clarke CS, Hu MT, Huxford B, Jha A, Lambert C, Lawton M, Mills G, Noyce A, Piccini P, Pushparatnam K, Rochester L, Siu C, Williams-Gray CH, Zeissler ML, Zetterberg H, Carroll CB, Foltynie T, Schrag A; EJS ACT-PD Consortium. Gonzalez-Robles C, et al. J Parkinsons Dis. 2023;13(6):1011-1033. doi: 10.3233/JPD-230051. J Parkinsons Dis. 2023. PMID: 37545260 Free PMC article. Clinical Trial.
Clinical trial designs and endpoints.
Zeissler ML, Chapman R. Zeissler ML, et al. Among authors: chapman r. Handb Clin Neurol. 2024;205:123-134. doi: 10.1016/B978-0-323-90120-8.00013-7. Handb Clin Neurol. 2024. PMID: 39341649 Review.
Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.
Zeissler ML, Bakshi N, Bartlett M, Batla A, Byrom D, Chapman R, Collins S, Cowd E, Deeson E, Ellis-Doyle R, Forbes J, Gonzalez-Robles C, Jewell A, Lane EL, LaPelle NR, Martin K, Matthews H, Miller L, Mills G, Morgan A, Parry M, Pushparatnam K, Ratcliffe N, Salathiel D, Scurfield P, Siu C, Whipps S, Wonnacott S, Foltynie T, Carroll CB, McFarthing K; EJS ACT-PD consortium. Zeissler ML, et al. Among authors: chapman r. J Parkinsons Dis. 2024;14(4):809-821. doi: 10.3233/JPD-230444. J Parkinsons Dis. 2024. PMID: 38701161 Free PMC article.
Predicting high-performance decathlon career best.
Battles P (he/him/his), Noble TJ (he/him/his), Chapman RF (he/him/his). Battles P (he/him/his), et al. Among authors: chapman rf he him his. Exp Physiol. 2025 Jan 9. doi: 10.1113/EP091921. Online ahead of print. Exp Physiol. 2025. PMID: 39787281
2,109 results